Jack Meehan
Stock Analyst at Barclays
(4.59)
# 58
Out of 4,415 analysts
79
Total ratings
68.12%
Success rate
14.15%
Average return
Main Sectors:
19 Stocks
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| A Agilent Technologies | Maintains: Underweight | $120 → $125 | $139.45 | -10.36% | 9 | Feb 28, 2024 | |
| WAT Waters | Maintains: Equal-Weight | $275 → $288 | $321.25 | -10.35% | 8 | Aug 3, 2023 | |
| DGX Quest Diagnostics | Maintains: Equal-Weight | n/a | $137.38 | - | 5 | Apr 23, 2020 | |
| LH Laboratory Corporation of America Holdings | Maintains: Overweight | n/a | $201.32 | - | 7 | Apr 23, 2020 | |
| ICLR ICON PLC | Maintains: Overweight | n/a | $309.02 | - | 2 | Apr 23, 2020 | |
| MYGN Myriad Genetics | Maintains: Underweight | n/a | $19.47 | - | 6 | Mar 26, 2020 | |
| IQV IQVIA Holdings | Maintains: Overweight | n/a | $223.37 | - | 4 | Mar 26, 2020 | |
| INMD InMode | Maintains: Overweight | n/a | $17.64 | - | 1 | Mar 26, 2020 | |
| ILMN Illumina | Maintains: Overweight | n/a | $117.93 | - | 7 | Mar 26, 2020 | |
| HOLX Hologic | Maintains: Equal-Weight | n/a | $76.54 | - | 4 | Mar 26, 2020 | |
| CRL Charles River Laboratories International | Maintains: Equal-Weight | n/a | $233.47 | - | 3 | Mar 26, 2020 | |
| BIO Bio-Rad Laboratories | Maintains: Overweight | n/a | $279.83 | - | 1 | Mar 26, 2020 | |
| AVTR Avantor | Maintains: Overweight | n/a | $24.72 | - | 1 | Mar 26, 2020 | |
| QDEL QuidelOrtho | Downgrades: Equal-Weight | n/a | $42.50 | - | 9 | Mar 26, 2020 | |
| BRKR Bruker | Upgrades: Overweight | n/a | $70.05 | - | 2 | Mar 26, 2020 | |
| MTD Mettler-Toledo International | Upgrades: Equal-Weight | n/a | $1,251.95 | - | 2 | Mar 26, 2020 | |
| TMO Thermo Fisher | Maintains: Overweight | n/a | $572.38 | - | 5 | Mar 18, 2019 | |
| BRO Brown & Brown | Maintains: Underweight | n/a | $83.50 | - | 2 | Nov 12, 2018 | |
| INCR InterCure | Initiates: Equal-Weight | n/a | $3.12 | - | 1 | Dec 11, 2017 |
Agilent Technologies
Feb 28, 2024
Maintains: Underweight
Price Target: $120 → $125
Current: $139.45
Upside: -10.36%
Waters
Aug 3, 2023
Maintains: Equal-Weight
Price Target: $275 → $288
Current: $321.25
Upside: -10.35%
Quest Diagnostics
Apr 23, 2020
Maintains: Equal-Weight
Price Target: n/a
Current: $137.38
Upside: -
Laboratory Corporation of America Holdings
Apr 23, 2020
Maintains: Overweight
Price Target: n/a
Current: $201.32
Upside: -
ICON PLC
Apr 23, 2020
Maintains: Overweight
Price Target: n/a
Current: $309.02
Upside: -
Myriad Genetics
Mar 26, 2020
Maintains: Underweight
Price Target: n/a
Current: $19.47
Upside: -
IQVIA Holdings
Mar 26, 2020
Maintains: Overweight
Price Target: n/a
Current: $223.37
Upside: -
InMode
Mar 26, 2020
Maintains: Overweight
Price Target: n/a
Current: $17.64
Upside: -
Illumina
Mar 26, 2020
Maintains: Overweight
Price Target: n/a
Current: $117.93
Upside: -
Hologic
Mar 26, 2020
Maintains: Equal-Weight
Price Target: n/a
Current: $76.54
Upside: -
Charles River Laboratories International
Mar 26, 2020
Maintains: Equal-Weight
Price Target: n/a
Current: $233.47
Upside: -
Bio-Rad Laboratories
Mar 26, 2020
Maintains: Overweight
Price Target: n/a
Current: $279.83
Upside: -
Avantor
Mar 26, 2020
Maintains: Overweight
Price Target: n/a
Current: $24.72
Upside: -
QuidelOrtho
Mar 26, 2020
Downgrades: Equal-Weight
Price Target: n/a
Current: $42.50
Upside: -
Bruker
Mar 26, 2020
Upgrades: Overweight
Price Target: n/a
Current: $70.05
Upside: -
Mettler-Toledo International
Mar 26, 2020
Upgrades: Equal-Weight
Price Target: n/a
Current: $1,251.95
Upside: -
Thermo Fisher
Mar 18, 2019
Maintains: Overweight
Price Target: n/a
Current: $572.38
Upside: -
Brown & Brown
Nov 12, 2018
Maintains: Underweight
Price Target: n/a
Current: $83.50
Upside: -
InterCure
Dec 11, 2017
Initiates: Equal-Weight
Price Target: n/a
Current: $3.12
Upside: -